Intrinsic Value of S&P & Nasdaq Contact Us

AmerisourceBergen Corporation ABC NYSE

NYSE • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
51/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$171.00
-5%

AmerisourceBergen Corporation (ABC) generated $-2.31B in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $119.38M, free cash flow was $-2.42B.

Free cash flow margin was -2.8% of revenue. Cash conversion ratio was -4.12x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (33/100, Fail) — weak cash flow raises concerns about debt servicing
  • MOAT (49/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (30/100) — Cash conversion ratio was -4.12x suggests some earnings are non-cash items

Overall SharesGrow Score: 51/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
51/100
SG Score
View full scorecard →
~
VALUE
53/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
47/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
49/100
Proven by this page
~
GROWTH
48/100
→ Income
INCOME
30/100
→ Income
AmerisourceBergen Corporation Cash Flow History
Metric TTM Q1 FY2026 Q4 FY2025 Q3 FY2025 Q2 FY2025
Operating Cash Flow $4.29B$-2.31B$3.13B$109.25M$3.35B
Capital Expenditure $-681.46M$-119.38M$-249.81M$-183.22M$-129.06M
Free Cash Flow $3.61B$-2.42B$2.88B$-73.97M$3.22B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message